Evidence-based educational guide for patients and caregivers — FDA-approved uses, dosing guidelines, safety warnings, and clinical insights for severe chronic pain relief for US patients
Medically reviewed by U.S. Licensed Pharmacists | Last updated: July 2026
Oxycodone 30mg (Oxycodone Hydrochloride) is a potent semi‑synthetic opioid analgesic approved by the U.S. Food and Drug Administration (FDA) for the management of severe, persistent pain that requires around‑the‑clock treatment.[1] It is frequently prescribed for cancer pain, post‑surgical pain, and pain from serious injuries. It is one of the most widely prescribed medications for severe pain management in the United States, valued for its potency and reliable efficacy. Millions of American patients have used Oxycodone to manage severe chronic pain effectively.
Image Size: 800×600px — Oxycodone mechanism of action: μ-opioid receptor agonism
Oxycodone works primarily by binding to μ‑opioid receptors in the central nervous system. This action inhibits the release of pain‑transmitting neurotransmitters, effectively reducing the perception of pain. It also modulates the emotional response to pain, providing both analgesic and mild euphoric effects.[2]
📌 Related Guide: Learn more about Tramadol 100mg — a less potent analgesic with a different mechanism.
Image Size: 800×600px — Oxycodone FDA-approved clinical indications for US patients
Oxycodone 30mg is indicated for the following conditions based on FDA approval and clinical guidelines:[1][3]
Note: Results vary per individual. Oxycodone should be used as part of a comprehensive pain management plan under strict medical supervision.
Image Size: 800×600px — Oxycodone key information and specifications for US patients
| Drug Class | Opioid Analgesic (Full μ‑Opioid Receptor Agonist) |
|---|---|
| FDA-Approved Indications | Severe Chronic Pain, Cancer Pain, Post‑Surgical Pain, Injury‑Related Pain |
| Active Ingredient | Oxycodone Hydrochloride |
| Onset of Action | 30–60 Minutes (Immediate‑Release) |
| Duration of Effect | 4–6 Hours |
| Elimination Half-Life | 3–5 Hours (Average ~4 hours) |
| Available Strengths | 5mg, 10mg, 15mg, 20mg, 30mg |
| Prescription Status | Schedule II Controlled Substance — Prescription required in the USA |
| Common Brand Names | OxyContin (ER), Roxicodone (IR), Percocet (with acetaminophen) |
Source: FDA Label for Oxycodone (Oxycodone Hydrochloride) — see references.
Image Size: 800×600px — Oxycodone common and serious side effects
While Oxycodone is highly effective for severe pain, it can cause side effects. Most are dose-related and may diminish with continued therapy. Contact your healthcare provider immediately if you experience severe or persistent side effects.
Image Size: 800×600px — Oxycodone drug interactions and contraindications
📌 Related Medication: If you are exploring other pain relief options, read our evidence-based guide on Tramadol 100mg to compare mechanisms and dosing schedules.
📘 Also See: Our comprehensive guide on Soma 350mg for muscle spasm and back pain relief.
Image Size: 800×600px — Oxycodone pharmacology and metabolic pathways
Oxycodone is rapidly and completely absorbed following oral administration. Peak plasma concentrations are achieved within 1 to 2 hours. The oral bioavailability of oxycodone is approximately 60-80%, making it highly effective when taken by mouth. The drug is moderately lipophilic, allowing it to cross the blood-brain barrier effectively and exert its central nervous system effects.
Once absorbed, oxycodone is extensively distributed throughout the body. Approximately 38-45% of the drug is bound to plasma proteins. The volume of distribution is approximately 2-3 L/kg. Its moderate lipophilicity contributes to its rapid onset and intermediate duration of action.
Oxycodone is extensively metabolized in the liver via the CYP450 enzyme system, primarily CYP3A4 and CYP2D6. The major metabolic pathways involve O-demethylation to form oxymorphone (via CYP2D6) and N-demethylation to form noroxycodone (via CYP3A4). Both metabolites have analgesic activity, with oxymorphone being a potent opioid agonist. The CYP2D6 polymorphism can significantly affect the analgesic efficacy of oxycodone.
The elimination half-life of oxycodone ranges from 3 to 5 hours, with an average of approximately 4 hours. The half-life of its active metabolites contributes to the overall duration of action. This intermediate half-life profile allows for convenient dosing every 4 to 6 hours for immediate-release formulations.
Oxycodone and its metabolites are primarily excreted in the urine. In patients with renal impairment (creatinine clearance less than 60 mL/min), dose adjustment is required due to reduced clearance. In patients with hepatic impairment, the metabolism of oxycodone may be significantly reduced, necessitating dose reduction or alternative therapy.
📌 Also See: Our guide on Tramadol 100mg — a less potent analgesic with a different pharmacological profile.
📌 Compare: Soma 350mg — a muscle relaxant for a different type of pain.
Images are for illustrative purposes only. This medication is available by prescription only.
📋 About This Medication
Oxycodone 30mg (Oxycodone Hydrochloride) is a potent opioid analgesic used for the management of severe chronic pain, cancer pain, and post-surgical pain. It works by binding to μ-opioid receptors in the brain to reduce pain perception.
This information is for educational purposes only. Always consult your healthcare provider.
📞 Check Availability →This guide is based on evidence from the following authoritative sources. All information is reviewed and updated regularly to reflect the latest clinical guidelines and FDA recommendations.
[1] U.S. Food and Drug Administration — DailyMed: Oxycodone (Oxycodone Hydrochloride) Label Information. NIH National Library of Medicine.
[2] National Institutes of Health — MedlinePlus. Oxycodone: MedlinePlus Drug Information. NIH. Updated 2026.
[3] American Pain Society. Clinical Practice Guideline for the Management of Chronic Pain in Adults. 2022.
[4] National Institute of Neurological Disorders and Stroke. Chronic Pain — NINDS. NIH. Updated 2026.
[5] U.S. Drug Enforcement Administration. Controlled Substance Schedules — Schedule II. DEA.
[6] National Center for Biotechnology Information. Oxycodone — StatPearls. NCBI.
Last reviewed and updated: July 14, 2026. This page is intended for educational purposes and should not replace professional medical advice.